Drugmakers uninterested in Trump's order to split up MMR vaccine
The Hill · 25 days ago

President Trump's executive order recommending that the measles, mumps and rubella (MMR) vaccine be split up across three different appointments is drawing poor reception from the pharmaceutical industry as drugmakers and trade groups say there's no scientific reasoning to follow the directive.
Continue reading at The Hill →















